Pharmaceutical solutions & Specialty ingredients

About SEQENS group

Our main activities

A leader in
Pharmaceutical synthesis

Discover

A strong expertise in
Specialty Ingredients

Discover

A complete and integrated
R&D offer

Discover

Committed to developing
and sustainably producing

Discover

Newsroom

#Live

General

Scientific Council : Seqens new solid state capabilities and services

Seqens held on 8 June 2021 its 2nd Scientific Commitee. On this occasion, our new solid state capabilities and services addressing our customers’s…
Read more
General / Press Release

Inauguration of the Labcom HitCat in partnership with the CNRS in the Seqens’Lab

The Labcom HitCat (High-Throughput Catalysis center) was inaugurated in partnership with the CNRS in the Seqens’Lab. Their common objective is to develop innovative…
Read more
Press Release

With the support of the France Relance programme and in partnership with Sanofi and UPSA, SEQENS has officially launched the project to build a new paracetamol production unit.

After a full year of R&D studies, SEQENS has officially launched the project to build a new paracetamol production unit, in partnership with…
Read more
See all news

Join the Seqens team!

Joining Seqens is a unique opportunity to participate in an exciting growth project with a strong international dimension and a strong entrepreneurial spirit.

Seqens global presence

Use interactive map
0

Employees

0

Scientists, experts and engineers

0

Manufacturing sites

0

Customers in more than 80 countries